touchPODCAST

Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape

touchEXPERT OPINIONS for touchONCOLOGY

In this activity, Prof. Thomas Powles, an oncologist specializing in bladder cancer, provides an update on the latest developments in the treatment of advanced urothelial carcinoma, including the latest guideline recommendations, supporting clinical data and factors to support decision making in clinical practice.

The expert

• Prof. Thomas Powles, Barts Cancer Centre, London, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is jointly funded by an independent medical education grant from Astellas Pharma Inc. and Seagen Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

https://touchoncologyime.org/advanced-urothelial-carcinoma-expert-guidance-to-navigate-an-evolving-therapeutic-landscape

Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer

touchEXPERT OPINIONS for touchONCOLOGY

A gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clinical practice.

The expert

• Prof. David Cibula, General University Hospital and Charles University, Prague, Czech Republic

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Merck & Co, Inc.  This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

https://touchoncologyime.org/immunotherapy-in-endometrial-cancer/

Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions

touchEXPERT OPINIONS for touchIMMUNOLOGY

Three experts share their insights on how to optimize the care of patients with bronchiolitis obliterans syndrome, including the disease pathogenesis and the burden on patients, guideline-directed diagnostic strategies, and current and future treatment options.

The experts

• Dr Michael Perch – University of Copenhagen, Copenhagen, Denmark
• Dr Howard J Huang –  Houston Methodist and Weill Cornell Medical College, Houston, TX, USA
• Dr Aldo Iacono –  Hofstra University/Northwell Health, Hempstead, NY, USA

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical educational grant from Zambon. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
touchimmunologyime.org/eo-management-of-bos

Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions

touchEXPERT OPINIONS for touchRESPIRATORY

Three experts share their insights on how to optimize the care of patients with bronchiolitis obliterans syndrome, including the disease pathogenesis and the burden on patients, guideline-directed diagnostic strategies, and current and future treatment options.

The experts

• Dr Michael Perch – University of Copenhagen, Copenhagen, Denmark
• Dr Howard J Huang –  Houston Methodist and Weill Cornell Medical College, Houston, TX, USA
• Dr Aldo Iacono –  Hofstra University/Northwell Health, Hempstead, NY, USA

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical educational grant from Zambon. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
touchrespiratoryime.org/eo-management-of-bos

Gastrointestinal oncology experts discuss precision medicine in the treatment of colorectal cancer

touchIN CONVERSATION for touchONCOLOGY

Listen to Dr Juan Manuel O’Connor, a leading expert in colorectal cancer from Argentina, in conversation with Prof. Dr. Francesco Sclafani, a gastrointestinal oncology specialist from Belgium. They respond to questions submitted by the HCP audience and provide their expert insights on the use of precision medicine in the treatment of patients with colorectal cancer.

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchoncology.com

Current treatments and unmet needs in limited-stage small cell lung cancer

touchFOCUS for touchRESPIRATORY

Listen to a medical oncologist share her insights on the current treatments for LS-SCLC and the remaining unmet needs for patients.

The expert

• Dr Anne Chiang – Yale School of Medicine, New Haven, CT, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 
https://touchrespiratoryime.org/focus-current-treatments-and-unmet-needs-in-LS-SCLC

Current treatments and unmet needs in limited-stage small cell lung cancer

touchFOCUS for touchONCOLOGY 

Listen to a medical oncologist share her insights on the current treatments for LS-SCLC and the remaining unmet needs for patients.

The expert:

• Dr Anne Chiang – Yale School of Medicine, New Haven, CT, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 
https://touchoncologyime.org/focus-current-treatments-and-unmet-needs-in-LS-SCLC

How to recognize and diagnose agitation in Alzheimer’s dementia – Discussion 5

touchMDT for touchNEUROLOGY

Listen to an advocate for individuals and families living with Alzheimer’s and other dementias interview a former Alzheimer’s dementia care partner; they explore the challenges of diagnosing agitation in Alzheimer’s dementia and the importance of a patient-centric multidisciplinary care team that encompasses care partners.

 

The multidisciplinary team

• Advocate: Ms Jennifer Pettis, Washington DC, USA
• Care partner: Dr Bonnie Burman, New Albany, OH, USA

 

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).

Understanding agitation in Alzheimer’s dementia – Discussion 4

touchMDT for touchNEUROLOGY

Listen to an advocate for individuals and families living with Alzheimer’s and other dementias interview a former Alzheimer’s dementia care partner to share personal insights of how agitation impacts not only the person living with dementia but everyone around them.

 

The multidisciplinary team

• Advocate: Ms Jennifer Pettis, Washington DC, USA
• Care partner: Dr Bonnie Burman, New Albany, OH, USA

 

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).

Managing agitation in Alzheimer’s dementia – Discussion 3

touchMDT for touchNEUROLOGY

Listen to key experts from a multidisciplinary team discuss best practice management approaches for agitation in Alzheimer’s dementia.

 

The multidisciplinary team

• Geriatric psychiatrist: Prof. George T Grossberg, St Louis, MO, USA 
• Cognitive neurologist: Dr Alireza Atri, Sun City, AZ, USA
• Nurse practitioner: Ms Susan Scanland, Clarks Summit, PA, USA 

 

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).